John P. Sharp
2012 - Ligand Pharmaceuticals
In 2012, John P. Sharp earned a total compensation of $782.6K as Former VP, Finance and Chief Financial Officer at Ligand Pharmaceuticals, a 31% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $102,382 |
|---|---|
| Option Awards | $312,365 |
| Salary | $292,519 |
| Stock Awards | $72,350 |
| Other | $2,985 |
| Total | $782,601 |
Sharp received $312.4K in option awards, accounting for 40% of the total pay in 2012.
Sharp also received $102.4K in non-equity incentive plan, $292.5K in salary, $72.4K in stock awards and $3K in other compensation.
Rankings
In 2012, John P. Sharp's compensation ranked 7,131st out of 11,487 executives tracked by ExecPay. In other words, Sharp earned more than 37.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,131 out of 11,487 | 38th |
Division Manufacturing | 2,554 out of 4,253 | 40th |
Major group Chemicals And Allied Products | 653 out of 1,203 | 46th |
Industry group Drugs | 450 out of 925 | 51st |
Industry Pharmaceutical Preparations | 353 out of 700 | 50th |
Source: SEC filing on March 12, 2015.
Sharp's colleagues
We found four more compensation records of executives who worked with John P. Sharp at Ligand Pharmaceuticals in 2012.